Table 1.
Conditions for which Tazocin® was prescribed empirically and appropriateness of prescription
| Provisional diagnosis | Total (column) | Appropriate | Inappropriate | Total (row) |
|---|---|---|---|---|
| Community-acquired UTI | 49 (8.0%) | 13 (25.0) | 36 (75.0) | 49 (100.0) |
| Peritonitis | 24 (4.0%) | 0 (0.0) | 24 (100.0) | 24 (100.0) |
| Acute cholycystitis | 12 (2.0%) | 0 (0.0) | 12 (100.0) | 12 (100.0) |
| Aspiration pneumonia | 49 (8.0%) | 0 (0.0) | 49 (100.0) | 49 (100.0) |
| Community acquired pneumonia | 43 (7.0%) | 0 (0.0) | 43 (100.0) | 43 (100.0) |
| Febrile neutropenia | 12 (2.0%) | 12 (100.0) | 0 (0.0) | 12 (100.0) |
| Line related sepsis | 55 (9.0%) | 49 (89.0) | 6 (11.0) | 55 (100.0) |
| Nosocomial pneumonia | 61 (10.0%) | 61 (100.0) | 0 (0.0) | 61 (100.0) |
| Nosocomial UTI | 12 (2.0%) | 6 (50.0) | 6 (50.0) | 12 (100.0) |
| Peritonitis with CAPD | 12 (2.0%) | 0 (0.0) | 12 (100.0) | 12 (100.0) |
| SBP | 12 (2.0%) | 0 (0.0) | 12 (100.0) | 12 (100.0) |
| Sepsis | 207 (34.0%) | 207 (100.0) | 0 (0.0) | 207 (100.0) |
| Skin and soft tissue infection | 31 (5.0%) | 0 (0.0) | 31 (100.0) | 31 (100.0) |
| Others | 31 (5.0%) | 0 (0.0) | 31 (100.0) | 31 (100.0) |
| Total | 610 (100.0%) | 348 (57.0) | 262 (43.0) | 610 (100.0) |
Abbreviations: UTI, urinary tract infection; CAPD, continuous ambulatory peritoneal dialysis; SBP, spontaneous bacterial peritonitis.